35 related articles for article (PubMed ID: 12799552)
1. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
Spacek LA; Griswold M; Quinn TC; Moore RD
AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Three-Parameter Scoring System for Monitoring HIV/AIDS Patients in Low-Resource Settings Using Hematological Parameters.
Al-Mughales JA
HIV AIDS (Auckl); 2023; 15():599-610. PubMed ID: 37818243
[TBL] [Abstract][Full Text] [Related]
3. Rapid Clinical Progression and Its Correlates Among Acute HIV Infected Men Who Have Sex With Men in China： Findings From a 5-Year Multicenter Prospective Cohort Study.
Zhang J; Huang XJ; Tang WM; Chu Z; Hu Q; Liu J; Ding H; Han X; Zhang Z; Jiang YJ; Geng W; Xia W; Xu J; Shang H
Front Immunol; 2021; 12():712802. PubMed ID: 34367176
[TBL] [Abstract][Full Text] [Related]
4. Profile of pneumocystis infection in a tertiary care institute in North India.
Kaur R; Panda PS; Dewan R
Indian J Sex Transm Dis AIDS; 2016; 37(2):143-146. PubMed ID: 27890947
[TBL] [Abstract][Full Text] [Related]
5. Correlation of CD4+ T cell Count with Total Lymphocyte Count, Haemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-1 Disease.
Sen S; Vyas A; Sanghi S; Shanmuganandan K; Gupta RM; Kapila BK; Praharaj AK; Kumar S; Batra RB
Med J Armed Forces India; 2011 Jan; 67(1):15-20. PubMed ID: 27365755
[TBL] [Abstract][Full Text] [Related]
6. An Evaluation of Alternative Markers to Guide Initiation of Anti-retroviral Therapy in HIV-Infected Children in Settings where CD4 Assays are not Available.
Huibers MH; Moons P; Maseko N; Gushu MB; Wit FW; Graham SM; van Hensbroek MB; Calis JC
J Trop Pediatr; 2016 Feb; 62(1):19-28. PubMed ID: 26491058
[TBL] [Abstract][Full Text] [Related]
7. Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count.
Dhamangaonkar AC; Mathew A; Pazare AR
West Indian Med J; 2014 Sep; 63(5):460-4. PubMed ID: 25781283
[TBL] [Abstract][Full Text] [Related]
8. Is total lymphocyte count a predictor for CD4 cell count in initiation antiretroviral therapy in HIV-infected patients?
Abdollahi A; Saffar H; Shoar S; Jafari S
Niger Med J; 2014 Jul; 55(4):289-93. PubMed ID: 25114362
[TBL] [Abstract][Full Text] [Related]
9. Utility of absolute lymphocyte count as a surrogate marker of CD4 cell counts: Is it useful?
Sagar A; Pathak A; Ambiya V; Naithani N; Vasudevan B; Agrawal S
Med J Armed Forces India; 2014 Jan; 70(1):48-52. PubMed ID: 24936121
[TBL] [Abstract][Full Text] [Related]
10. Utility of total lymphocyte count as a surrogate for absolute CD4 count in the adult Indian HIV population: A prospective study.
Karanth SS; Rau NR; Gupta A; Kamath A; Shanbhogue V; Pruthvi BC
Avicenna J Med; 2014 Jan; 4(1):1-4. PubMed ID: 24678463
[TBL] [Abstract][Full Text] [Related]
11. Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia.
Wondimeneh Y; Ferede G; Yismaw G; Muluye D
AIDS Res Ther; 2012 Jul; 9(1):21. PubMed ID: 22793790
[TBL] [Abstract][Full Text] [Related]
12. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
Obirikorang C; Quaye L; Acheampong I
BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
[TBL] [Abstract][Full Text] [Related]
13. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
[TBL] [Abstract][Full Text] [Related]
14. Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.
Baveewo S; Ssali F; Karamagi C; Kalyango JN; Hahn JA; Ekoru K; Mugyenyi P; Katabira E
PLoS One; 2011 May; 6(5):e19089. PubMed ID: 21589912
[TBL] [Abstract][Full Text] [Related]
15. Prediction based classification for longitudinal biomarkers.
Foulkes AS; Azzoni L; Li X; Johnson MA; Smith C; Mounzer K; Montaner LJ
Ann Appl Stat; 2010 Sep; 4(3):1476-1497. PubMed ID: 21274424
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.
Brown ER; Otieno P; Mbori-Ngacha DA; Farquhar C; Obimbo EM; Nduati R; Overbaugh J; John-Stewart GC
J Infect Dis; 2009 May; 199(9):1292-300. PubMed ID: 19317628
[TBL] [Abstract][Full Text] [Related]
17. Relationship between total lymphocyte count (TLC) and CD4 count among peoples living with HIV, Southern Ethiopia: a retrospective evaluation.
Daka D; Loha E
AIDS Res Ther; 2008 Dec; 5():26. PubMed ID: 19102769
[TBL] [Abstract][Full Text] [Related]
18. Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
Musoke PM; Young AM; Owor MA; Lubega IR; Brown ER; Mmiro FA; Mofenson LM; Jackson JB; Fowler MG; Guay LA
J Acquir Immune Defic Syndr; 2008 Oct; 49(2):171-8. PubMed ID: 18769352
[TBL] [Abstract][Full Text] [Related]
19. Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index.
Moore DM; Awor A; Downing RS; Were W; Solberg P; Tu D; Chan K; Hogg RS; Mermin J
AIDS Res Ther; 2007 Jan; 4():1. PubMed ID: 17233896
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
